These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes. Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E; Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304 [TBL] [Abstract][Full Text] [Related]
8. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial. Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393 [TBL] [Abstract][Full Text] [Related]
9. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903 [TBL] [Abstract][Full Text] [Related]
11. Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial. Haidar A; Legault L; Matteau-Pelletier L; Messier V; Dallaire M; Ladouceur M; Rabasa-Lhoret R Lancet Diabetes Endocrinol; 2015 Aug; 3(8):595-604. PubMed ID: 26066705 [TBL] [Abstract][Full Text] [Related]
13. [From insulin pump and continuous glucose monitoring to the artificial pancreas]. Apablaza P; Soto N; Codner E Rev Med Chil; 2017 May; 145(5):630-640. PubMed ID: 28898340 [TBL] [Abstract][Full Text] [Related]
14. The artificial pancreas: current status and future prospects in the management of diabetes. Peyser T; Dassau E; Breton M; Skyler JS Ann N Y Acad Sci; 2014 Apr; 1311():102-23. PubMed ID: 24725149 [TBL] [Abstract][Full Text] [Related]
15. Artificial Pancreas Device Systems for the Closed-Loop Control of Type 1 Diabetes: What Systems Are in Development? Trevitt S; Simpson S; Wood A J Diabetes Sci Technol; 2016 May; 10(3):714-23. PubMed ID: 26589628 [TBL] [Abstract][Full Text] [Related]
16. "Learning" Can Improve the Blood Glucose Control Performance for Type 1 Diabetes Mellitus. Wang Y; Zhang J; Zeng F; Wang N; Chen X; Zhang B; Zhao D; Yang W; Cobelli C Diabetes Technol Ther; 2017 Jan; 19(1):41-48. PubMed ID: 28060528 [TBL] [Abstract][Full Text] [Related]
17. Progress of artificial pancreas devices towards clinical use: the first outpatient studies. Russell SJ Curr Opin Endocrinol Diabetes Obes; 2015 Apr; 22(2):106-11. PubMed ID: 25692927 [TBL] [Abstract][Full Text] [Related]
18. Closed-loop insulin delivery: from bench to clinical practice. Hovorka R Nat Rev Endocrinol; 2011 Feb; 7(7):385-95. PubMed ID: 21343892 [TBL] [Abstract][Full Text] [Related]
19. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes. Rodbard D Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879 [TBL] [Abstract][Full Text] [Related]
20. Closing the loop: combining insulin pumps and glucose sensors in children with type 1 diabetes mellitus. Shalitin S; Phillip M Pediatr Diabetes; 2006 Aug; 7 Suppl 4():45-9. PubMed ID: 16774618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]